| Rank | Ticker | Exchange | Country | Price | Revenue | Analyst Rating | IPO Year |
|---|---|---|---|---|---|---|---|
#1 | DMRC | Nasdaq | United States | $4.91 | $0.00 | Strong Buy | 2026 |
#2 | GENB | Nasdaq | United States | $15.18 | $0.00 | Strong Buy | 2026 |
#3 | XOM | Nasdaq | United States | $160.67 | $0.00 | Buy | 2026 |
#4 | MWH | Nasdaq | United States | $25.12 | $0.00 | Strong Buy | 2026 |
#5 | BOBS | Nasdaq | United States | $13.74 | $0.00 | Buy | 2026 |
#6 | FPS | Nasdaq | United States | $38.92 | $1,420,059,000.00 | Buy | 2026 |
#7 | REAX | Nasdaq | United States | $16.43 | $0.00 | Strong Buy | 2026 |
#8 | EIKN | Nasdaq | United States | $7.92 | $0.00 | Buy | 2026 |
#9 | SGP | Nasdaq | United States | $27.03 | $0.00 | Strong Buy | 2026 |
#10 | DYAI | Nasdaq | United States | $0.42 | $3,090,345.00 | Strong Buy | 2026 |
#11 | DAIO | Nasdaq | United States | $2.85 | $21,500,000.00 | Strong Buy | 2026 |
#12 | MANE | Nasdaq | United States | $117.12 | $0.00 | Strong Buy | 2026 |
#13 | CRMT | Nasdaq | United States | $1.06 | $1,281,502,000.00 | Buy | 2026 |
The FinQuota filters have identified what they believe to be the "Best New Stocks & Recent IPOs (September 2026) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.